FDA Investigators Talk Quality Issues And Inspectional ‘Games’ Manufacturers Play
• By Shawn M. Schmitt
There are plenty of typical mistakes that FDA investigators find when inspecting device firms, from failing to adequately document complaints and ensuring proper process validation, to developing ambiguous design inputs during design control activities. Yet what really grates investigators’ nerves is when they have to ask manufacturers several times for procedures and processes that are routinely asked for during an inspection. “Let’s get beyond the things that you know are going to be needed and have them readily available,” says Phil Pontikos, an agency investigator and FDA’s national device expert. In fact, firms that attempt to conceal information or stall an investigator leave themselves open to additional scrutiny by the agency. “If you want to play games, then quite frankly, we’re going to dig deep,” Pontikos says.
Device manufacturers that attempt to avoid sharing quality system information with FDA during a facility inspection can stretch the time of the audit and create unnecessary friction between the agency and firms, FDA investigators say.
“My pet peeve is when companies play games. I hate that they know what I’m asking for but I have...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
